Parminder Kaur is a regulatory affairs expert and an EU QPPV having 19+ years of recognized global expertise in a broad range of therapy areas. She has also played a major role in setting the in-house RA and PV systems in compliance with the European regulations at various companies.
In 2011, she led an IMI Project on combination therapy at EFPIA, in close collaboration with Research & Development Group (RDG) at European Commission. In March 2007, Mrs. Kaur had been selected by the European Federation of Pharmaceutical Industries and Association (EFPIA) for her global expertise and also had an honor to be the Scientific Representative from India for the year 2000-2001, duly sponsored by UNESCO.
Parminder had also been a speaker, panelist and Masterclass provider at various National and international Conferences. Parminder is the founder of RA&PV Consultancy, RegPak Biopharma Consulting based in Amsterdam.
Early access programs, (EAPs) are adopted by an increasing number of pharma companies due to several benefits offered by these programs.